Cargando…

Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome

OBJECTIVE: Little is known about developmental outcomes in neonatal abstinence syndrome (NAS). We hypothesized that children treated for NAS would score lower than the normative sample on the Bayley Scales of Infant Development, 3(rd) edition. STUDY DESIGN: We performed a retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Merhar, Stephanie L., McAllister, Jennifer M., Wedig-Stevie, Kathryn E., Klein, Amy C., Meinzen-Derr, Jareen, Poindexter, Brenda B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999528/
https://www.ncbi.nlm.nih.gov/pubmed/29515225
http://dx.doi.org/10.1038/s41372-018-0088-9
_version_ 1783331444171472896
author Merhar, Stephanie L.
McAllister, Jennifer M.
Wedig-Stevie, Kathryn E.
Klein, Amy C.
Meinzen-Derr, Jareen
Poindexter, Brenda B.
author_facet Merhar, Stephanie L.
McAllister, Jennifer M.
Wedig-Stevie, Kathryn E.
Klein, Amy C.
Meinzen-Derr, Jareen
Poindexter, Brenda B.
author_sort Merhar, Stephanie L.
collection PubMed
description OBJECTIVE: Little is known about developmental outcomes in neonatal abstinence syndrome (NAS). We hypothesized that children treated for NAS would score lower than the normative sample on the Bayley Scales of Infant Development, 3(rd) edition. STUDY DESIGN: We performed a retrospective cohort study of 87 infants treated for NAS and evaluated at 2 years of age. RESULTS: Children treated for NAS scored significantly lower than the norm (mean 100) on all 3 subscales (cognitive mean 96.5, language mean 93.8, motor mean 94.0, all p<0.03). Children who lived with foster/adoptive families at follow up had higher cognitive scores (median 100 vs 95, p=0.03) than those who lived with biological relatives, and were less likely to have motor scores <85 (p = 0.02). Eight percent of children required treatment for strabismus. CONCLUSIONS: Children treated for NAS are at risk for lower developmental scores and higher rates of strabismus at age 2 than the general population.
format Online
Article
Text
id pubmed-5999528
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-59995282018-09-07 Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome Merhar, Stephanie L. McAllister, Jennifer M. Wedig-Stevie, Kathryn E. Klein, Amy C. Meinzen-Derr, Jareen Poindexter, Brenda B. J Perinatol Article OBJECTIVE: Little is known about developmental outcomes in neonatal abstinence syndrome (NAS). We hypothesized that children treated for NAS would score lower than the normative sample on the Bayley Scales of Infant Development, 3(rd) edition. STUDY DESIGN: We performed a retrospective cohort study of 87 infants treated for NAS and evaluated at 2 years of age. RESULTS: Children treated for NAS scored significantly lower than the norm (mean 100) on all 3 subscales (cognitive mean 96.5, language mean 93.8, motor mean 94.0, all p<0.03). Children who lived with foster/adoptive families at follow up had higher cognitive scores (median 100 vs 95, p=0.03) than those who lived with biological relatives, and were less likely to have motor scores <85 (p = 0.02). Eight percent of children required treatment for strabismus. CONCLUSIONS: Children treated for NAS are at risk for lower developmental scores and higher rates of strabismus at age 2 than the general population. 2018-03-07 2018-05 /pmc/articles/PMC5999528/ /pubmed/29515225 http://dx.doi.org/10.1038/s41372-018-0088-9 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Merhar, Stephanie L.
McAllister, Jennifer M.
Wedig-Stevie, Kathryn E.
Klein, Amy C.
Meinzen-Derr, Jareen
Poindexter, Brenda B.
Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
title Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
title_full Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
title_fullStr Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
title_full_unstemmed Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
title_short Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
title_sort retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999528/
https://www.ncbi.nlm.nih.gov/pubmed/29515225
http://dx.doi.org/10.1038/s41372-018-0088-9
work_keys_str_mv AT merharstephaniel retrospectivereviewofneurodevelopmentaloutcomesininfantstreatedforneonatalabstinencesyndrome
AT mcallisterjenniferm retrospectivereviewofneurodevelopmentaloutcomesininfantstreatedforneonatalabstinencesyndrome
AT wedigsteviekathryne retrospectivereviewofneurodevelopmentaloutcomesininfantstreatedforneonatalabstinencesyndrome
AT kleinamyc retrospectivereviewofneurodevelopmentaloutcomesininfantstreatedforneonatalabstinencesyndrome
AT meinzenderrjareen retrospectivereviewofneurodevelopmentaloutcomesininfantstreatedforneonatalabstinencesyndrome
AT poindexterbrendab retrospectivereviewofneurodevelopmentaloutcomesininfantstreatedforneonatalabstinencesyndrome